Th17 Inducing Cytokines Pregnancy and After Postpartum
- Conditions
- Pregnancy
- Interventions
- Other: Saliva collectionOther: GCF collection
- Registration Number
- NCT03449186
- Lead Sponsor
- Aydin Adnan Menderes University
- Brief Summary
The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of IL-17A, IL-17E, IL-6 AND IL-23 during 2/3 trimester of pregnancy and after delivery.
- Detailed Description
IL-17 have a synergytic effect with IL-6 and IL-23. IL-17A levels elevated with periodontal diseases. Many systemical chronic conditions such as atherosclerosis and cardiovascular disease, pregnancy may contribute increasing of IL-17 family cytokine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 114
- women 2 and 3 trimester of their pregnancy
- any known systemic disease,
- periodontal treatment within the last six months,
- patients having less than 10 teeth,
- smokers,
- individuals with a BMI > 30 kg/m2,
- gestational diabetes and preeclampsia during pregnancy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Postpartum group Saliva collection Postpartum women 6 months after giving birth recalled. Saliva and GCF samples were collected and clinical periodontal measurements were made. Postpartum group GCF collection Postpartum women 6 months after giving birth recalled. Saliva and GCF samples were collected and clinical periodontal measurements were made. Pregnancy group Saliva collection Women, who were in their second trimester (weeks 16-24) or third trimester (weeks 25-34)selected for the study. Saliva and GCF samples were collected and clinical periodontal measurements were made gently Pregnancy group GCF collection Women, who were in their second trimester (weeks 16-24) or third trimester (weeks 25-34)selected for the study. Saliva and GCF samples were collected and clinical periodontal measurements were made gently
- Primary Outcome Measures
Name Time Method Changing Il-17A levels 6 month Salivary and GCF level measured by ELISA
- Secondary Outcome Measures
Name Time Method Changing IL-6 levels 6 month Salivary and GCF level measured by ELISA
Changing IL-23 levels 6 month Salivary and GCF level measured by ELISA
Changing IL-17E levels 6 month Salivary and GCF level measured by ELISA